Latest News and Press Releases

Seattle, WA, May 04, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced two key leadership appointments....

Dublin, Sept. 14, 2022 (GLOBE NEWSWIRE) -- The "Global Protein Engineering Market (2022-2027) by Product & Service, Protein Type, Technology, End User, Geography, Competitive Analysis, and the...

Dublin, March 16, 2022 (GLOBE NEWSWIRE) -- The "Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of...

London, March 10, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Protein Design and Engineering Market, 2021 - 2035” report to its list of offerings Owing to the various...

• Combined company capitalized with approximately $65M to develop novel immunotherapies • Sophisticated computational platform enables new class of de novo protein therapeutics • Lead program,...

SEATTLE and SAN FRANCISCO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arzeda, the Protein Design Company™, Twist Bioscience Corporation, TeselaGen Biotechnology Inc. and Labcyte Inc. have partnered to build...

SEATTLE and HOUSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design Company™, and BP announced a collaboration to develop a process for producing a renewable chemical with broad...

SEATTLE, Jan. 16, 2018 (GLOBE NEWSWIRE) -- In a release issued under the same headline on December 21, 2017 by Arzeda, we are advised by the company that "OP Fund" in the second paragraph should...

SEATTLE, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design CompanyTM, today announced that biotechnology veteran William “Bill” Baum has joined the company’s board of directors. Baum is a...

SEATTLE, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design CompanyTM, today announced that it has officially closed its Series A funding round with a total investment of $15.2 million. ...